Search for LIMS content across all our Wiki Knowledge Bases.
Type a search term to find related articles by LIMS subject matter experts gathered from the most trusted and dynamic collaboration tools in the laboratory informatics industry.
Makrofagno stimulišući proteinski receptor je protein koji je kod ljudi kodiran MST1Rgenom.[1][2] MST1R je takođe poznat kao RON (Recepteur d'Origine Nantais) kinaza, pri čemu ime potiče od francuskog grada u kome je otkriven. On je srodan sa c-MET receptorskom tirozinsko kinazom.[1][3]
↑Li BQ, Wang MH, Kung HF, Ronsin C, Breathnach R, Leonard EJ, Kamata T (November 1995). „Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor”. Biochem. Biophys. Res. Commun.216 (1): 110–8. DOI:10.1006/bbrc.1995.2598. PMID7488076.
Li BQ, Wang MH, Kung HF, et al. (1995). „Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor”. Biochem. Biophys. Res. Commun.216 (1): 110–8. DOI:10.1006/bbrc.1995.2598. PMID7488076.
Wang MH, Ronsin C, Gesnel MC, et al. (1994). „Identification of the ron gene product as the receptor for the human macrophage stimulating protein”. Science266 (5182): 117–9. DOI:10.1126/science.7939629. PMID7939629.
Follenzi A, Bakovic S, Gual P, et al. (2000). „Cross-talk between the proto-oncogenes Met and Ron”. Oncogene19 (27): 3041–9. DOI:10.1038/sj.onc.1203620. PMID10871856.
Chen YQ, Zhou YQ, Fisher JH, Wang MH (2002). „Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo”. Oncogene21 (41): 6382–6. DOI:10.1038/sj.onc.1205783. PMID12214279.
Zhou YQ, He C, Chen YQ, et al. (2003). „Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential”. Oncogene22 (2): 186–97. DOI:10.1038/sj.onc.1206075. PMID12527888.
Penengo L, Rubin C, Yarden Y, Gaudino G (2003). „c-Cbl is a critical modulator of the Ron tyrosine kinase receptor”. Oncogene22 (24): 3669–79. DOI:10.1038/sj.onc.1206585. PMID12802274.
Maggiora P, Lorenzato A, Fracchioli S, et al. (2003). „The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness”. Exp. Cell Res.288 (2): 382–9. DOI:10.1016/S0014-4827(03)00250-7. PMID12915129.
Santoro MM, Gaudino G, Marchisio PC (2003). „The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration”. Dev. Cell5 (2): 257–71. DOI:10.1016/S1534-5807(03)00201-6. PMID12919677.
Angeloni D, Danilkovitch-Miagkova A, Miagkov A, et al. (2004). „The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation”. J. Biol. Chem.279 (5): 3726–32. DOI:10.1074/jbc.M309342200. PMID14597639.
van den Akker E, van Dijk T, Parren-van Amelsvoort M, et al. (2004). „Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors”. Blood103 (12): 4457–65. DOI:10.1182/blood-2003-08-2713. PMID14982882.
Raeppel S, Gaudette G, et al. (2010). „Identification of a novel series of potent RON receptor tyrosine kinase inhibitors”. Bioorg. Med. Chem. Lett.20 (9): 2745–9. DOI:10.1016/j.bmcl.2010.03.073.